Alto Neuroscience ANRO Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's accumulated depreciation?
- Alto Neuroscience (ANRO) reported accumulated depreciation of $1.71M in Q1 2026.
- How has Alto Neuroscience's accumulated depreciation changed year-over-year?
- Alto Neuroscience's accumulated depreciation increased by 47.7% year-over-year, from $1.16M to $1.71M.
- What is the long-term trend for Alto Neuroscience's accumulated depreciation?
- Over 2 years (2023 to 2025), Alto Neuroscience's accumulated depreciation has grown at a 49.4% compound annual growth rate (CAGR), from $684K to $1.53M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.